[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636522":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":19,"collaborators":10,"id":21,"slug":22,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":26,"acronym":27,"eligibilityCriteria":28,"healthyVolunteers":23,"sex":29,"minAge":30,"maxAge":10,"enrollmentInfo":31,"targetDuration":10,"studyType":34,"phases":10,"briefSummary":35,"conditions":36,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":10},{"fullName":5,"class":6},"Menarini Silicon Biosystems","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Pregnant women",null,[12],"Other: Blood collection",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","Blood collection","Samples of peripheral blood (30 ml) will be collected from pregnant women",[9],{"type":20,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100636522","cell-based-non-invasive-prenatal-test-workflow-100636522",false,"NCT07566780","Cell-based Non-invasive Prenatal Test Workflow","Prospective Collection of Maternal Venous Blood Samples for Cell-based Non- Invasive Prenatal Test Workflow","TOTAL#5","Inclusion Criteria:\n\n1. Informed consent signed before any study-specific procedures\n2. Pregnant women with singleton or twin pregnancy, at 8+0 - 14+6 week of gestation, aged ≥18 years\n3. No medical contraindication for collecting 30 ml blood sample\n\nExclusion Criteria:\n\n1. Unable to provide informed consent\n2. Known infections that carry a risk of vertical transmission\n3. Known maternal viral diseases: HIV and HCV, HBV","FEMALE","18 Years",{"count":32,"type":33},1400,"ESTIMATED","OBSERVATIONAL","The aim of this study is to optimize a new non-invasive prenatal screening method based on the capture of fetal cells from maternal blood and to complete its development by obtaining maternal blood samples during the first trimester of pregnancy.",[37],"Pregnant Women","NOT_YET_RECRUITING","2026-04-28",{"date":41,"type":42},"2026-05-05","ACTUAL",{"date":44,"type":33},"2026-05-04",{"date":46,"type":33},"2027-12-31",{"name":5,"class":6}]